Eliminate data silos and streamline workflows to improve operational efficiency

SAN DIEGO, CA — December 7, 2023 — Seqster PDM, Inc. ("SEQSTER") , the
industry leading patient-centric healthcare technology company, proudly unveils its
cutting-edge Connected Research and Development data refinery platform — a
revolutionary solution designed to seamlessly integrate siloed EHR, genomic, and
device data in diverse formats. This innovative tool parses, standardizes, and
transforms data into a clean, common form, eliminating barriers to comprehensive
healthcare insights.

In the healthcare industry, the disjointed nature of data silos has long been a barrier
to effective patient care and impeded progress in clinical research. Recognizing
this critical issue, SEQSTER introduces a cutting-edge solution that seamlessly
bridges data silos, enabling streamlined data sharing across a spectrum of
healthcare use cases. By providing a comprehensive view of health data,
SEQSTER aims to accelerate the pace of healthcare innovation and improve
confidence in critical decision-making processes.

“The pharmaceutical industry has spoken, and we've listened. Today, I am thrilled
to announce the launch of SEQSTER CoRD, a groundbreaking platform designed
to revolutionize the way pharma companies manage and utilize their R&D data,”
said Ardy Arianpour, CEO and co-founder of SEQSTER. “This innovative tool
directly addresses the industry's critical challenge of unlocking the vast potential of
its diverse and often fragmented data landscape. By seamlessly integrating clinical
trials, genomics, remote patient monitoring, and other valuable sources, the CoRD
creates a unified, standardized knowledge base. This empowers researchers with
unparalleled insights and AI-driven analytics.”

Key Features of the SEQSTER CoRD:

1. Data Integration Across Dimensions: CoRD seamlessly integrates genotypic
and phenotypic data, combining DNA, RNA, protein, metabolite, genomics,
transcriptomics, proteomics, metabolomics, clinical trials, and RWE into a unified
platform.
2. Target Discovery: Understand relationships between diseases, targets, and
drugs, establish biomarkers, and generate data and models crucial for accelerating
healthcare innovation.
3. Drug Discovery: Repurpose existing drugs, generate novel drug candidates, and
validate and optimize drug candidates using cutting-edge drug design technology.
4. Drug Development: Design and run pre-clinical experiments, clinical trials,
recruit for clinical trials, and optimize for efficiency and effectiveness.
5. Post-Approval: Publish evidence and demonstrate real-world effectiveness
post-approval, contributing to the ongoing evolution of healthcare science.

SEQSTER's CoRD is designed to serve as a comprehensive solution for
pharmaceutical companies, researchers, and healthcare professionals looking to
streamline and enhance their research and development efforts.